What is Doximity, Inc.'s (DOCS) StockRank?

MoatMap's StockRank for Doximity, Inc. (DOCS) is 62/100, with a Hold signal. This is a composite score combining Quality (86), Value (48), and Momentum (21) factor ranks across MoatMap's 20,000+ stock universe.

Does Doximity, Inc. have an economic moat?

Doximity, Inc. (DOCS) has a Quality factor score of 86/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Doximity, Inc. a buy, hold, or sell?

MoatMap's current signal for Doximity, Inc. (DOCS) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Doximity, Inc. in?

Doximity, Inc. (DOCS) operates in the Healthcare sector, specifically the Health Information Services industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

DOCS

HOLD

Doximity, Inc. · Healthcare · United States · $3.7B · Avg Vol: $68M/d

StockRank

Get insider-trade alerts

P/E (TTM)

21.9x

ROE

19.3%

D/E

0.0x

Dividend %

—

COMPANY DESCRIPTION

Doximity, Inc. operates the largest digital platform for U.S. medical professionals, offering tools for collaboration, news, telehealth, and career opportunities. The company's network effect, with a vast majority of U.S. physicians as members, creates a powerful competitive moat, attracting both users and pharmaceutical advertisers. Doximity serves as a critical digital hub for physicians, providing a highly engaged audience for healthcare communication and marketing.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	2026	CAGR	TTM	2027E	2028E	Fwd CAGR
Revenue	343.5M	419.1M	475.4M	570.4M	644.9M	17.0%	644.9M	670.3M	712.4M	5.1%
EPS	0.82	0.58	0.78	1.19	1.05	6.4%	0.99	0.99	1.10	2.4%
Shares	192.4M	193.9M	186.6M	188.9M	183.1M	-4.9%	—	—	—	—
Debt	1.1M	15.6M	14.5M	12.4M	10.2M	74.9%	10.2M	—	—	—
Equity	878.6M	966.1M	901.4M	1.1B	950.8M	2.0%	—	—	—	—
Op CF	126.6M	179.6M	184.1M	273.3M	326.5M	26.7%	326.5M	—	—	—
Inv CF	-640.6M	-59.9M	31.2M	-29.3M	147.2M	—	—	—	—	—
Fin CF	560.4M	-74.5M	-276.5M	-131.1M	-464.1M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+4.7%

SMA 50SMA 200

$20.99

RSI (14)

35.2

52W High

$76.51

From 52W High

0.3%

SCORE BREAKDOWN

Quality

ROIC

20.8%92.1

ROE

19.3%88.0

GP/Assets

45.4%84.9

Op. Margin

21.6%85.2

FCF/Assets

20.2%96.3

Piotroski

668.3

Int. Cover

50.0x88.8

D/E Ratio

0.01x84.0

Current Ratio

6.09x76.2

Value

P/E (TTM)

21.9x53.9

EV/EBITDA

14.1x48.7

P/FCF

14.4x69.6

P/B

4.2x33.0

P/S

6.1x36.5

Div Yield

—N/A

Momentum

52W High %

27%6.6

RS 6M

-56%11.0

SMA 50/200

0.60x3.6

EPS Rev 4W

-0.2%47.4

EPS Rev 12W

-1.7%35.3

EPS Improve

+61%60.3

Q Growth

-69%5.1

FUNDAMENTALS

Market Cap

$3.7B

P/E (Forward)

13.6x

Gross Margin

89.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DOCS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
DOCS	Doximity, Inc.(you)	$3.7B	62	HOLD
WAY	Waystar Holding Corp.	$4.3B	65	HOLD
PRVA	Privia Health Group, Inc.	$3.2B	57	HOLD
OMCL	Omnicell, Inc.	$1.9B	66	BUY
TXG	10x Genomics, Inc.	$5.9B	75	BUY
OMDA	Omada Health, Inc.	$1.2B	62	HOLD
HNGE	Hinge Health, Inc.	$5.8B	81	STRONG BUY
CERT	Certara, Inc.	$1.2B	55	HOLD
TALK	Talkspace, Inc.	$873M	64	HOLD
TDOC	Teladoc Health, Inc.	$1.6B	77	BUY

Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.5%